Synthetic patients
04
in current review queue
Transparent cascade review
Find the story behind the next prescription.
CascadeGuard surfaces synthetic medication sequences worth a clinician’s review—showing exactly what matched, when it happened, and what evidence supports the signal.
Unresolved signals
02
awaiting review
High-risk priority
02
risk score ≥ 70
Evidence patterns
04
transparent rules
Prioritized review
Prescription cascade risk queue
Sorted by unresolved cascade risk.
| Patient | Likely sequence | Signal | Risk | Open patient |
|---|---|---|---|---|
MC Mara Chen 72 years · Hypertension · Osteoarthritis | Amlodipine → Furosemide Symptom-supported match | Needs review | 92/100 | |
TB Theo Brooks 69 years · Mild cognitive impairment · GERD | Donepezil → Loperamide Chronology-only partial match | Needs review | 74/100 | |
AN Alma Njoroge 80 years · Major neurocognitive disorder · Fall risk | Rivastigmine → Oxybutynin Symptom-supported match | Monitoring | 65/100 | |
DO David Ortiz 63 years · Hypertension · Type 2 diabetes | Lisinopril → Benzonatate Symptom-supported match | Reviewed | 46/100 |
Risk score prioritizes unresolved, chronology-supported signals. Synthetic case set